
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
International Agency for Research on Cancer, F-69372 Lyon, France [N. M., A-M. C-R., S. L., M. L., P. B.]; Institut Municipal dInvestigació Mèdica, E-08003 Barcelona, Spain [N. M.]; Institute of Environmental Medicine, Karolinska Institute, S-17177 Stockholm, Sweden [F. N.]; Bremen Institute for Prevention Research, D-28199 Bremen, Germany [W.A.]; Institute of Public Health, R-76256 Bucharest, Romania [V. C.]; Institute of Carcinogenesis, Cancer Research Center, 115478 Moscow, Russia [A. Mu.]; INSERM U157, F-94805 Villejuif, France [S. B.]; Pneumological Hospital, 60-568 Poznan, Poland [H. B-G.]; GSF Institute for Epidemiology, D-85758 Munich, Germany [I. B-H.]; Veneto Cancer Registry, Department of Oncology, University of Padua, I-35128 Padua, Italy [L. S.]; Federal University of Rio Grande do Sul, 96100 Pelotas, RG, Brazil [A. Me.]; School of Public Health, University of California, Berkeley, California 94720-7360 [S. L.]; and Uppsala University, S-75123 Uppsala, Sweden [M. L.]
Glutathione S-transferase (GST) polymorphism may contribute to the individual variability in detoxifying lung carcinogens. This effect might be particularly relevant at low-level exposure to environmental carcinogens, such as in nonsmokers exposed to environmental tobacco smoke (ETS). We conducted a case-control study among 122 nonsmoking lung cancer cases and 121 nonsmoking controls from eight countries. Information on environmental exposures was obtained through a personal interview. The presence of GSTM1 and GSTT1 genes was determined using multiplex PCR. GSTM1-positive samples were then analyzed for *1A and *1B polymorphism using an allele-specific amplification-PCR method. GSTM1*2 (null) individuals had an odds ratio (OR) of lung cancer of 1.5 [95% confidence interval (CI), 0.92.7]; the risk associated with this genotype was higher for cases with squamous and small cell carcinomas (OR, 2.3; 95% CI, 0.96.1) than for cases with adenocarcinomas. It was also elevated in individuals with long-term exposure to indoor wood combustion (OR, 3.1; 95% CI, 0.99.9), in subjects who mainly lived in a rural setting (OR, 3.6; 95% CI, 1.013), and in cases exposed to occupational carcinogens (OR, 10.7; 96% CI, 0.4260) but not in subjects exposed to ETS. GSTT1*2 subjects did not show a risk of lung cancer. Our study suggests that the effect of GSTM1 polymorphism in nonsmokers is similar to that found in smokers. It does not seem to interact with ETS exposure, although we cannot exclude that it does in association with exposure to other specific environmental carcinogens.
This article has been cited by other articles:
![]() |
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Taylor, F. Najafi, and A. Dobson Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent Int. J. Epidemiol., October 1, 2007; 36(5): 1048 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Raimondi, V Paracchini, H Autrup, J. Barros-Dios, S Benhamou, P Boffetta, M. Cote, I. Dialyna, V Dolzan, R Filiberti, et al. Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review Am. J. Epidemiol., December 1, 2006; 164(11): 1027 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pisani, P. Srivatanakul, J. Randerson-Moor, S. Vipasrinimit, S. Lalitwongsa, P. Unpunyo, S. Bashir, and D. T. Bishop GSTM1 and CYP1A1 Polymorphisms, Tobacco, Air Pollution, and Lung Cancer: A Study in Rural Thailand. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 667 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Orozco-Levi, J. Garcia-Aymerich, J. Villar, A. Ramirez-Sarmiento, J. M. Anto, and J. Gea Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur. Respir. J., March 1, 2006; 27(3): 542 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mazzone, J. C. Chagoya, and A. C. Arroliga Cause and Effect in Lung Cancer: Fueling the Fire Chest, July 1, 2005; 128(1): 6 - 8. [Full Text] [PDF] |
||||
![]() |
P Vineis, L Airoldi, F Veglia, L Olgiati, R Pastorelli, H Autrup, A Dunning, S Garte, E Gormally, P Hainaut, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study BMJ, February 5, 2005; 330(7486): 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.S. Wenzlaff, M.L. Cote, C.H. Bock, S.J. Land, and A.G. Schwartz GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study Carcinogenesis, February 1, 2005; 26(2): 395 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Georgiadis, J. Topinka, D. Vlachodimitropoulos, M. Stoikidou, M. Gioka, G. Stephanou, H. Autrup, N. A. Demopoulos, K. Katsouyanni, R. Sram, et al. Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations Carcinogenesis, January 1, 2005; 26(1): 93 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cohet, S. Borel, F. Nyberg, A. Mukeria, I. Bruske-Hohlfeld, V. Constantinescu, S. Benhamou, P. Brennan, J. Hall, and P. Boffetta Exon 5 Polymorphisms in the O6-Alkylguanine DNA Alkyltransferase Gene and Lung Cancer Risk in Non-Smokers Exposed to Second-Hand Smoke Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 320 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davey Smith Effect of passive smoking on health BMJ, May 15, 2003; 326(7398): 1048 - 1049. [Full Text] [PDF] |
||||
![]() |
R. J. Hung, P. Boffetta, J. Brockmoller, D. Butkiewicz, I. Cascorbi, M. L. Clapper, S. Garte, A. Haugen, A. Hirvonen, S. Anttila, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis Carcinogenesis, May 1, 2003; 24(5): 875 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stucker, A. Hirvonen, I. de Waziers, A. Cabelguenne, K. Mitrunen, S. Cenee, E. Koum-Besson, D. Hemon, P. Beaune, and M.-A. Loriot Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility Carcinogenesis, September 1, 2002; 23(9): 1475 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benhamou, W. J. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M. L. Clapper, A. Daly, V. Dolzan, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk Carcinogenesis, August 1, 2002; 23(8): 1343 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Miller, G. Liu, I. De Vivo, T. J. Lynch, J. C. Wain, L. Su, and D. C. Christiani Combinations of the Variant Genotypes of GSTP1, GSTM1, and p53 Are Associated with an Increased Lung Cancer Risk Cancer Res., May 1, 2002; 62(10): 2819 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al. Metabolic Gene Polymorphism Frequencies in Control Populations Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1239 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stucker, P. Boffetta, S. Antilla, S. Benhamou, A. Hirvonen, S. London, and E. Taioli Lack of Interaction between Asbestos Exposure and Glutathione S-Transferase M1 and T1 Genotypes in Lung Carcinogenesis Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1253 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lewis, P. Brennan, F. Nyberg, W. Ahrens, V. Constantinescu, A. Mukeria, S. Benhamou, H. Batura-Gabryel, I. Bruske-Hohlfeld, L. Simonato, et al. Re: Spitz, M. R., Duphorne, C. M., Detry, M. A., Pillow, P. C., Amos, C. I., Lei, L., de Andrade, M., Gu, X., Hong, W. K., and Wu, X. Dietary Intake of Isothiocyanates: Evidence of a Joint Effect with Glutathione S-Transferase Polymorphisms in Lung Cancer Risk. Cancer Epidemiol. Biomark. Prev., 9: 1017-1020, 2000 Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1105 - 1106. [Full Text] [PDF] |
||||
![]() |
B. Pignatelli, C.-Q. Li, P. Boffetta, Q. Chen, W. Ahrens, F. Nyberg, A. Mukeria, I. Bruske-Hohlfeld, C. Fortes, V. Constantinescu, et al. Nitrated and Oxidized Plasma Proteins in Smokers and Lung Cancer Patients Cancer Res., January 1, 2001; 61(2): 778 - 784. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |